Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007-2014)

J Neurovirol. 2017 Jun;23(3):451-459. doi: 10.1007/s13365-017-0519-y. Epub 2017 Feb 21.

Abstract

The aim of the study was to describe the clinical and epidemiological characteristics of the central nervous system (CNS) infection by varicella zoster virus (VZV) in patients older than 65 years in a tertiary community hospital. We retrospectively analysed the results of cerebrospinal fluid (CSF) testing in patients older than 65 years between 2007 and 2014 with clinically suspected VZV infection with CNS involvement. Patients whose CSF samples were positive for VZV DNA were included, as were those with negative results who simultaneously presented herpes zoster and CSF or magnetic resonance imaging findings suggestive of CNS infection, and in whom other possible aetiologies had been ruled out. The study included 280 patients. The disease was considered to be caused by a VZV infection in 32 patients (11.4%), of which 23 cases were virologically confirmed (detection of VZV DNA in CSF). The most frequent diagnosis of the patients with VZV CNS infection was encephalitis (83.3%), followed by meningitis (13.3%) and cerebellitis (3.3%). The mean annual incidence of VZV CNS infection was 3.0 cases per 100,000 inhabitants. VZV was the most common cause of encephalitis and viral meningitis, ahead of herpes simplex virus (n = 9). At the time of discharge, 12 (40%) patients showed neurological sequelae. Five patients (20%) died during hospitalization, all with encephalitis. Patients with a fatal outcome had significantly higher median age and longer delay before initiating acyclovir. In conclusion, VZV was the first cause of encephalitis in our elderly population. Despite acyclovir treatment, there was a high rate of case fatality and sequelae at discharge.

Keywords: Central nervous system infection; Encephalitis; Epidemiology; Herpes simplex virus; Varicella zoster virus.

MeSH terms

  • Acyclovir / therapeutic use
  • Aged
  • Aged, 80 and over
  • Antiviral Agents / therapeutic use
  • Central Nervous System / pathology
  • Central Nervous System / virology
  • DNA, Viral / cerebrospinal fluid*
  • Encephalitis, Varicella Zoster / diagnostic imaging
  • Encephalitis, Varicella Zoster / drug therapy
  • Encephalitis, Varicella Zoster / epidemiology*
  • Encephalitis, Varicella Zoster / mortality
  • Female
  • Herpesvirus 3, Human / drug effects
  • Herpesvirus 3, Human / pathogenicity*
  • Herpesvirus 3, Human / physiology
  • Humans
  • Incidence
  • Magnetic Resonance Imaging
  • Male
  • Meningitis, Viral / diagnostic imaging
  • Meningitis, Viral / drug therapy
  • Meningitis, Viral / epidemiology*
  • Meningitis, Viral / mortality
  • Retrospective Studies
  • Spain / epidemiology
  • Survival Analysis
  • Varicella Zoster Virus Infection / diagnostic imaging
  • Varicella Zoster Virus Infection / drug therapy
  • Varicella Zoster Virus Infection / epidemiology*
  • Varicella Zoster Virus Infection / mortality

Substances

  • Antiviral Agents
  • DNA, Viral
  • Acyclovir